Legend Biotech Corp. (LEGN)
33.48
+1.96
(+6.22%)
USD |
NASDAQ |
Jun 09, 16:00
33.48
0.00 (0.00%)
After-Hours: 18:15
Legend Biotech SG&A Expense (Quarterly) : 90.37M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Protagonist Therapeutics, Inc. | 13.28M |
| AbbVie, Inc. | 3.578B |
| Capricor Therapeutics, Inc. | 9.396M |
| Viking Therapeutics, Inc. | 13.98M |
| Arcutis Biotherapeutics, Inc. | 74.08M |